ArticleBMC chemistry2025
Spectroscopic approaches for structural analysis of extracted chitosan generated from chitin deacetylated for escalated periods.
Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chitosan from shrimp shell waste as a carrier for frankincense nanoparticles with enhanced antimicrobial activity.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A conventional chemical method was applied for the extraction of chitosan (CH) from shrimp shell wastes (SSWs) in three stages: (1) Demineralization: SSWs were treated with HCl to remove minerals. (2) Deproteinization: NaOH was used to eliminate proteins from the demineralization shells. 3: Deacetylation: The chitin (CT) obtained from stage 2 was converted to chitosan in alkaline medium using NaOH. This study aims to demonstrate the impact of varying deacetylation times on chitosan surface morphology, elemental composition, thermal resistance, structural configuration, and deacetylation degree (DD). Variable techniques including UV-visible spectroscopy, Fourier Transformed Infra-Red (FTIR-ATR), Thermogravimetry (TG/DTG), Scanning Electron Microscopy (SEM), and Energy-dispersive X-ray spectroscopy (EDX) analyses were employed to analyze how increased deacetylation periods affect the characterization of the products. The FTIR spectra showed a notable similarity between all extracted chitosan processed with increasing deacetylation time and the commercial one. Moreover, the results revealed that all the extracted chitosan samples acquired DD values, based on FTIR-ATR analysis, are comparable to that of commercial ones i.e. 79.54%, 78.23%, 74.81%, and 76.56% for deacetylated times of 22 h, 30 h, 36 h, and 40 h, respectively are comparable to that of the commercial chitosan (76.1%). Furthermore, the EDX analysis confirms that the extracted chitosan is non-toxic product, making it suitable for various applications, including biological and medical uses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.